Soleus Private Equity GP III, LLC 3
3 · Parabilis Medicines, Inc. · Filed Jun 29, 2026
Insider Transaction Report
Form 3
Levy Guy
10% Owner
Holdings
- (indirect: See footnote)
Series F Preferred Stock
[F2][F1]Exercise: $9.48→ Common Stock (527,070 underlying)
Footnotes (2)
- [F1]The reportable securities are owned directly by Soleus Private Equity Fund III, L.P. ("Soleus PE"). Soleus Private Equity GP III, LLC ("Soleus PE GP") is the sole general partner of Soleus PE, Soleus PE GP III, LLC is the sole manager of Soleus PE GP, Soleus Capital Management, L.P. ("SCM") is the investment manager for Soleus PE, and Soleus GP, LLC ("Soleus GP") is the sole general partner of SCM. Guy Levy is the sole managing member of each of Soleus PE GP III, LLC and Soleus GP. Each of Mr. Levy, Soleus PE GP III, LLC, Soleus PE GP, SCM and Soleus GP disclaims beneficial ownership of the securities held by Soleus PE other than for the purpose of determining their obligations under Section 16 of the Securities Exchange Act of 1934, as amended, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such securities for any other purpose, except to the extent of their respective pecuniary interests therein.
- [F2]The convertible preferred stock is convertible at any time, at the holder's election, and has no expiration date.